UK markets close in 2 hours 26 minutes

Achilles Therapeutics plc (ACHL)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
0.7744-0.0151 (-1.91%)
At close: 04:00PM EDT
0.7700 -0.01 (-1.41%)
Pre-market: 07:06AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-69,665
-69,665
-71,176
-61,099
-33,199
Depreciation & amortisation
4,713
4,713
3,690
3,288
772
Stock-based compensation
6,357
6,357
7,022
6,317
2,992
Change in working capital
10,409
10,409
-5,956
-7,931
3,004
Accounts payable
257
257
1,907
-2,572
5,258
Other working capital
-49,549
-49,549
-67,047
-66,918
-37,099
Other non-cash items
-276
-276
-601
-18
1,179
Net cash provided by operating activities
-48,449
-48,449
-59,535
-59,284
-25,252
Cash flows from investing activities
Investments in property, plant and equipment
-1,100
-1,100
-7,512
-7,634
-11,847
Net cash used for investing activities
-1,100
-1,100
-7,512
-7,634
-11,847
Cash flows from financing activities
Common stock issued
9
9
1
0
0
Other financing activities
-
-
-
-
-121
Net cash used provided by (used for) financing activities
9
9
1
160,755
113,704
Net change in cash
-41,799
-41,799
-92,981
88,503
80,255
Cash at beginning of period
173,371
173,371
266,352
177,849
97,594
Cash at end of period
131,572
131,572
173,371
266,352
177,849
Free cash flow
Operating cash flow
-48,449
-48,449
-59,535
-59,284
-25,252
Capital expenditure
-1,100
-1,100
-7,512
-7,634
-11,847
Free cash flow
-49,549
-49,549
-67,047
-66,918
-37,099